Medications for analgesia and sedation in the intensive care unit: an overview
Open Access
- 1 January 2008
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 12 (Suppl 3) , S4
- https://doi.org/10.1186/cc6150
Abstract
Critically ill patients are often treated with continuous intravenous infusions of sedative drugs. However, this is associated with high risk for over-sedation, which can result in prolonged stay in the intensive care unit. Recently introduced protocols (daily interruption and analgosedation) have proven to reduce the length of intensive care unit stay. To introduce these protocols, new agents or new regimens with the well established agents may be required. In this article we briefly discuss these new regimens and new agents, focusing on the short-acting substances.Keywords
This publication has 35 references indexed in Scilit:
- AnaConDa?? Reflection Filter: Bench and Patient Evaluation of Safety and Volatile Anesthetic ConservationAnesthesia & Analgesia, 2007
- Sedation and analgesia in the intensive care unit: Evaluating the role of dexmedetomidineAmerican Journal of Health-System Pharmacy, 2007
- Epidural analgesia improves outcome after multiple rib fracturesSurgery, 2004
- The Role of the α2-Adrenoceptor Agonist Dexmedetomidine in Postsurgical Sedation in the Intensive Care UnitJournal of Intensive Care Medicine, 2003
- Morphine-6-glucuronide, a potent mu agonistPublished by Elsevier ,2002
- Isoflurane and propofol for long‐term sedation in the intensive care unitAnaesthesia, 1992
- Isoflurane for prolonged sedation in the intensive care unit; efficacy and safetyIntensive Care Medicine, 1992
- Isoflurane compared with midazolam for sedation in the intensive care unit.BMJ, 1989
- NALTREXONE PRETREATMENT ATTENUATES SIDE EFFECTS OF EPIDURAL MORPHINEAnesthesiology, 1986
- The Extent of Metabolism of Inhaled Anesthetics in HumansAnesthesiology, 1986